Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Disclosed deployed
—
across known amounts
Stages
—
About
Novo Holdings, the primary shareholder of Novo Nordisk A/S and Novozymes A/S, manages a substantial investment portfolio with a focus on long-term returns. As the asset management arm of the Novo Nordisk Foundation—one of the world’s largest philanthropic enterprise foundations—Novo Holdings plays a central role in stewarding the Foundation's wealth. In addition to handling a broad mix of equities, bonds, real estate, infrastructure, and private equity assets, Novo Holdings is a global leader in life sciences investment. Through its Seeds, Venture, Growth, and Principal Investments teams, the company supports life science companies at every stage of development
Portfolio
No portfolio companies in this dataset yet.